跳至主要内容
临床试验/NL-OMON28819
NL-OMON28819招募中不适用

Transarterial Chemoembolization with Drug-Eluting Beads (standard arm) versus Stereotactic Body Radiation Therapy (experimental arm) for hepatocellular carcinoma: A multicenter randomized phase II trialThe TRENDY trial”

Erasmus MCDepartment of Radiotherapy0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must be discussed in a multidisciplinary liver tumor board and should meet all of the following criteria:
  • Patients diagnosed with HCC (follow the diagnostic algorithm recommended by the
  • EASL–EORTC Clinical Practice Guidelines 2012) [1].
  • Barcelona Clinic Liver Cancer Stage System class A-B
  • One tumor of maximum diameter ≤ 6 cm measured in all 3 axes. A maximum of two satellite nodules around the main tumor are accepted. Satellite nodules should fulfill the following criteria: Distance from the main tumor to the inner border of the nodules should be < 1 cm, maximum diameter of each nodule should be ≤ 5 mm, maximum diameter of the main tumor together with the nodules should be ≤ 6 cm in all 3 axes.
  • Measurable disease on CT/MRI-scan, according to mRECIST criteria for HCC within 6 weeks prior to randomization [44].
  • Tumor visibility on CT
  • Child-Pugh A cirrhosis
  • Age ≥ 18 years
  • ECOG performance status 0-1
  • Albumin> 28 g/l, bilirubin < 50 µmol/l, INR < 2.3, AST/ALT < 5 times ULN, within 6 weeks prior to randomization
  • Platelets ≥ 50x10E9/ l, neutrophils > 0.75x10E9/l, Hb > 6 mmol/l, within 6 weeks prior to randomization
  • Written informed consent
  • Willing and able to comply to the follow-up schedule
  • Planned to start treatment within 6 weeks from randomization.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Eligibility for resection or RFA
  • More than one tumor in the liver
  • Any signs of acute viral or non-viral hepatitis
  • Encephalopathy
  • Vascular tumor invasion (contact with the vessel will not be considered contraindication).
  • Previous radiotherapy to the liver
  • Known current pregnancy
  • Distance from the tumor to the esophagus, stomach, duodenum, small bowel or large bowel < 2 cm on CT or on MRI. Uncontrolled portal hypertension (high bleeding risk). If gastroscopy has been performed, untreated esophageal varices grade III or IV.

研究者

发起方
Erasmus MCDepartment of Radiotherapy

相似试验